MedTrace Logo

Effect of PeakATP on Mood, Reaction Time and Cognition

NCT05100589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-08-08

No results posted yet for this study

Summary

Oral ATP disodium (adenosine 5'- triphosphate disodium) is a commercially available product available alone and as a constituent in a number of sports supplements that is purported to maintain ATP levels and improve performance during high-intensity exercise. Acute deficits in cognitive performance have also been reported in both young adults and children following high-intensity exercise; however, the effects of supplemental ATP on cognitive performance has not been studied.

Goals:

1. To investigate the effect of ATP supplementation versus. placebo on mood, reaction time and cognitive performance before and after an acute bout of fatiguing exercise.
2. To investigate the effect of ATP supplementation versus. placebo on anaerobic performance.

Conditions

  • Cognitive Change
  • Mood

Interventions

DIETARY_SUPPLEMENT

PeakATP

Powder - 400mg Peak ATP, maltodextrin, silica-colloidal anhydrous, citric acid anhydrous, sucralose, guar gum

DIETARY_SUPPLEMENT

Placebo

Powder - maltodextrin, silica-colloidal anhydrous, citric acid anhydrous, sucralose, guar gum

Sponsors & Collaborators

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Adam J Wells, PhD · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-06
Primary Completion
2022-04-19
Completion
2022-04-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100589 on ClinicalTrials.gov